Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05010655 · ClinicalTrials.gov registry record
Low Ejection Fraction in Single Lead ECG
A clinical trial, sponsored by Eko Devices.
- Completed
- Registry status
- 1,935
- Enrollment target
NCT05010655: Completed study, sponsored by Eko Devices.
NCT05010655 is a clinical trial that has completed, run by Eko Devices. The registered enrollment target is 1,935 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05010655 has completed, sponsored by Eko Devices.
- COMPLETED
- Registry status
- 1,935 participants
- Enrollment target
Study Summary
The purpose of this research is to prospectively test and validate the single-lead Low EF algorithm in outpatients in order to test the performance of a single-lead ECG based algorithm to identify people with decreased left ventricular EF.
Primary Outcome
Evaluate performance of single-lead ECG based algorithm to identify individuals with reduced ejection fraction.
Interventions
- DEVICE Use of Eko DUO Electronic Stethoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,935 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2022-05-24 |
What the finished NCT05010655 record still lists
NCT05010655 is an observational study that tracks outcomes without assigning an intervention. Its 1,935 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Use of Eko DUO Electronic Stethoscope is the first listed.
NCT05010655 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05010655 about?
NCT05010655 is a clinical study titled "Low Ejection Fraction in Single Lead ECG". The purpose of this research is to prospectively test and validate the single-lead Low EF algorithm in outpatients in order to test the performance of a single-lead ECG based algorithm to identify people with decreased left ventricular EF.
What is the current status of trial NCT05010655?
This trial is currently completed. The enrollment target is 1,935 participants. The study started on 2021-06-01. Estimated completion is 2022-05-24.
What interventions are being tested in trial NCT05010655?
The interventions under investigation include: Use of Eko DUO Electronic Stethoscope (DEVICE).
Who is sponsoring clinical trial NCT05010655?
This trial is sponsored by Eko Devices, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
- NCT06058455 · 1,920 participants · NA
An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
- NCT04251052 · 1,956 participants · NA
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- NCT05174169 · 1,912 participants · Phase 2
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI